Epigenetic Regulation of Macrophage Polarization in Cardiovascular Diseases. 2023

Sumra Komal, and Sheng-Na Han, and Liu-Gen Cui, and Miao-Miao Zhai, and Yue-Jiao Zhou, and Pei Wang, and Muhammad Shakeel, and Li-Rong Zhang
Department of Pharmacology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou 450001, China.

Cardiovascular diseases (CVDs) are the leading cause of hospitalization and death worldwide, especially in developing countries. The increased prevalence rate and mortality due to CVDs, despite the development of several approaches for prevention and treatment, are alarming trends in global health. Chronic inflammation and macrophage infiltration are key regulators of the initiation and progression of CVDs. Recent data suggest that epigenetic modifications, such as DNA methylation, posttranslational histone modifications, and RNA modifications, regulate cell development, DNA damage repair, apoptosis, immunity, calcium signaling, and aging in cardiomyocytes; and are involved in macrophage polarization and contribute significantly to cardiac disease development. Cardiac macrophages not only trigger damaging inflammatory responses during atherosclerotic plaque formation, myocardial injury, and heart failure but are also involved in tissue repair, remodeling, and regeneration. In this review, we summarize the key epigenetic modifications that influence macrophage polarization and contribute to the pathophysiology of CVDs, and highlight their potential for the development of advanced epigenetic therapies.

UI MeSH Term Description Entries

Related Publications

Sumra Komal, and Sheng-Na Han, and Liu-Gen Cui, and Miao-Miao Zhai, and Yue-Jiao Zhou, and Pei Wang, and Muhammad Shakeel, and Li-Rong Zhang
May 2013, Trends in immunology,
Sumra Komal, and Sheng-Na Han, and Liu-Gen Cui, and Miao-Miao Zhai, and Yue-Jiao Zhou, and Pei Wang, and Muhammad Shakeel, and Li-Rong Zhang
January 2023, Burns & trauma,
Sumra Komal, and Sheng-Na Han, and Liu-Gen Cui, and Miao-Miao Zhai, and Yue-Jiao Zhou, and Pei Wang, and Muhammad Shakeel, and Li-Rong Zhang
April 2014, Molecular endocrinology (Baltimore, Md.),
Sumra Komal, and Sheng-Na Han, and Liu-Gen Cui, and Miao-Miao Zhai, and Yue-Jiao Zhou, and Pei Wang, and Muhammad Shakeel, and Li-Rong Zhang
January 2021, Frontiers in cardiovascular medicine,
Sumra Komal, and Sheng-Na Han, and Liu-Gen Cui, and Miao-Miao Zhai, and Yue-Jiao Zhou, and Pei Wang, and Muhammad Shakeel, and Li-Rong Zhang
September 2011, European journal of immunology,
Sumra Komal, and Sheng-Na Han, and Liu-Gen Cui, and Miao-Miao Zhai, and Yue-Jiao Zhou, and Pei Wang, and Muhammad Shakeel, and Li-Rong Zhang
November 2016, JCI insight,
Sumra Komal, and Sheng-Na Han, and Liu-Gen Cui, and Miao-Miao Zhai, and Yue-Jiao Zhou, and Pei Wang, and Muhammad Shakeel, and Li-Rong Zhang
January 2023, Frontiers in cardiovascular medicine,
Sumra Komal, and Sheng-Na Han, and Liu-Gen Cui, and Miao-Miao Zhai, and Yue-Jiao Zhou, and Pei Wang, and Muhammad Shakeel, and Li-Rong Zhang
January 2020, International journal of molecular sciences,
Sumra Komal, and Sheng-Na Han, and Liu-Gen Cui, and Miao-Miao Zhai, and Yue-Jiao Zhou, and Pei Wang, and Muhammad Shakeel, and Li-Rong Zhang
October 2014, Current opinion in lipidology,
Sumra Komal, and Sheng-Na Han, and Liu-Gen Cui, and Miao-Miao Zhai, and Yue-Jiao Zhou, and Pei Wang, and Muhammad Shakeel, and Li-Rong Zhang
May 2023, Biology,
Copied contents to your clipboard!